(MENAFN- Ameliorate Digital Consultancy)
According to the Market Statsville Group (MSG), the global androstenedione market size was valued at USD 206.4 million in 2022 , which is expected to reach USD 221.8 million by 2033 , growing at a CAGR of 2.8 % from 2023 to 2033.
The global androstenedione market is expected to grow at a moderate rate over the next few years, driven by factors such as the increasing demand for dietary supplements and the growing popularity of fitness and bodybuilding. However, regulatory concerns, negative side effects associated with the use of androstenedione, and the availability of alternative performance-enhancing drugs are likely to hinder the market growth. With a rise in the number of people adopting a plant-based diet, there is an increasing demand for plant-based supplements, including androstenedione, which is derived from plant sources, creating a lucrative growth opportunity for the market's growth.
Definition of the Global Androstenedione Market Androstenedione is a natural steroid hormone that is produced primarily in the adrenal glands, ovaries, and testes of humans and other animals. It is a precursor to the sex hormones testosterone and estrogen, which are important for developing male and female sexual characteristics, respectively. In recent years, androstenedione has gained popularity as a dietary supplement and a performance-enhancing drug. It is used by athletes and bodybuilders to increase muscle mass, energy, and endurance and is also marketed as a natural testosterone booster. However, several sports organizations have banned the use of androstenedione as a performance-enhancing drug due to concerns over its safety and efficacy. While androstenedione is naturally produced in the human body, it can also be synthesized in the laboratory and is available in various forms, including pills, capsules, and injections.
Request Sample Copy of this Report:
COVID – 19 Impact on the Global Androstenedione Market The growing interest in health and wellness during the pandemic has increased demand for dietary supplements and performance-enhancing drugs, including androstenedione. Many people have turned to supplements like androstenedione to boost their immune systems and improve their overall health. However, on the other hand, the pandemic has also led to disruptions in the global supply chain, causing shortages and price hikes for certain raw materials and finished products. Additionally, closing gyms and fitness centers during lockdowns has reduced demand for performance-enhancing drugs, including androstenedione. Furthermore, the use of androstenedione as a performance-enhancing drug has been banned in many sports organizations, and with the suspension or cancellation of many sports events during the pandemic, the market for such drugs has also been impacted. Overall, while the COVID-19 pandemic has presented some challenges for the androstenedione market, the growing interest in health and wellness is likely to sustain demand for dietary supplements in the long term.
Global Androstenedione Market Dynamics Drivers : Increasing Demand for Dietary Supplements The increasing demand for dietary supplements is one of the key drivers of the androstenedione market. Androstenedione is a popular dietary supplement that is widely used to improve energy, muscle mass, and athletic performance. A survey by the Council for Responsible Nutrition (CRN) found that 77% of American adults take dietary supplements, and 87% of those who use them believe that supplements positively impact their overall health. There has been a growing trend of people turning to dietary supplements to improve their overall health and well-being, particularly in developed countries where lifestyles have become more sedentary and diets often lack essential nutrients. This trend has driven the demand for androstenedione as a natural supplement that can boost energy levels and promote muscle growth.
In addition, the rising awareness about the benefits of sports and fitness activities has also contributed to the increasing demand for androstenedione. Many athletes and fitness enthusiasts use androstenedione to improve their physical performance, as it is believed to enhance endurance, strength, and power. Moreover, the increasing geriatric population has also significantly driven the demand for androstenedione supplements. With the aging of the population, the demand for supplements that can improve muscle strength and cognitive function is expected to increase. Thus, the increasing demand for dietary supplements, particularly those that can enhance physical performance, is expected to drive the growth of the androstenedione market. As more people turn to natural supplements to improve their health and fitness, the androstenedione market will likely continue growing in the coming years.
Restraints : Regulatory Concerns and Side Effects Regulatory concerns and side effects are two factors that can restrain the growth of the androstenedione market. Androstenedione is classified as a steroid hormone and is regulated by various government bodies, including the US Food and Drug Administration (FDA). The FDA has banned the sale of androstenedione as a dietary supplement in the US, citing concerns about its safety and effectiveness. Additionally, androstenedione is known to have several potential side effects, which can pose a risk to users' health. Some of the side effects associated with androstenedione use include an increased risk of heart disease, liver damage, and hormonal imbalances. There is also a risk of androstenedione interacting with other medications or supplements, which can lead to adverse reactions. These regulatory concerns and potential side effects can make consumers wary of using androstenedione and may limit the market's growth potential. In fact, many athletes and fitness enthusiasts have turned to safer and more regulated supplements in recent years.
Moreover, the negative publicity surrounding the use of androstenedione in professional sports has further contributed to regulatory concerns and restrained the market's growth. The use of androstenedione as a performance-enhancing drug is prohibited in many sports organizations, and athletes who are caught using it can face penalties and suspensions.
Opportunities : Advancements in Technology and Growing Demand for Plant-Based Supplements Advancements in technology and growing demand for plant-based supplements present a significant growth opportunity for the androstenedione market. Technology is playing a critical role in advancing the production and development of plant-based supplements, which can offer a safe and natural alternative to traditional synthetic supplements. In addition, advancements in extraction and purification technologies are making it easier to extract and refine androstenedione from plant sources, further driving the market growth. Moreover, plant-based supplements have gained popularity among vegan and vegetarian consumers looking for natural supplements that do not contain animal-derived ingredients. Plant-based supplements are also known to have fewer side effects than synthetic supplements, making them a more attractive option for health-conscious consumers.
Incorporating androstenedione into plant-based supplements can help manufacturers cater to this growing demand for natural and plant-based supplements. For example, androstenedione can be extracted from yams and soybeans and used to develop plant-based supplements that support muscle growth, improve athletic performance, and enhance overall health. Further, the advancement is the use of supercritical fluid extraction (SFE) technology, which uses supercritical fluids such as carbon dioxide to extract androstenedione from plants. This technique offers several advantages over traditional extraction methods, including higher yield, reduced extraction time, and lower solvent usage, making it more environmentally friendly and cost-effective. Another advancement is the use of nanotechnology in the production of androstenedione supplements.
Scope of the Global Androstenedione Market The study categorizes the androstenedione market based on product type, distribution channel, and application area at the regional and global levels.
Direct Purchase Report:
By Product Type Outlook ( Sales, USD Billion, 2019-2033 ) Androstenedione Androstadienedione
By Distribution Channel Outlook ( Sales, USD Billion, 2019-2033 ) Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Application Outlook ( Sales, USD Billion, 2019-2033 ) Infectious Inflammation Arthritis Fertility Control Others
By Region Outlook ( Sales, USD Billion, 2019-2033 ) North America Europe Germany Italy France UK Spain Poland Russia The Netherlands Norway Czech Republic Rest of Europe
Asia Pacific China Japan India South Korea Indonesia Malaysia Thailand Singapore Australia & New Zealand Rest of Asia Pacific
South America Brazil Argentina Colombia Rest of South America
The Middle East & Africa Saudi Arabia UAE South Africa Northern Africa Rest of MEA
Fertility control segment accounts for the largest market share by application Based on the application, the market is divided into infectious inflammation, arthritis, fertility control, and others. The fertility control segment is expected to dominate the market share in 2022 in the global androstenedione market. The fertility control segment of the androstenedione market includes products such as contraceptives and fertility treatments. With the increasing awareness about family planning and the need to control population growth, the demand for these products has been on the rise. Additionally, the increasing prevalence of infertility and reproductive disorders has led to an increased demand for fertility treatments, further driving the growth of this segment. Furthermore, the rising trend of delayed marriages and childbirth has created a significant demand for fertility control products, particularly in developed economies. As a result, the fertility control segment is expected to continue dominating the androstenedione market in the coming years. With advancements in technology and increasing research in this field, the market for androstenedione-based fertility control products is expected to witness substantial growth in the near future.
Asia Pacific is expected to witness the largest market share by Region Based on the regions, the global androstenedione market has been segmented across Europe, North America, the Middle East & Africa, Asia-Pacific, and South America. Asia Pacific is projected to account for the highest market share in 2022. The Asia Pacific region is home to several emerging economies, including India and China, which have a significant population and a growing demand for healthcare services. These countries have witnessed a rise in the prevalence of various reproductive disorders, which has led to an increased demand for fertility treatments and contraceptives, thereby driving the growth of the androstenedione market. Moreover, the increasing awareness about family planning and the need for population control has created a significant demand for fertility control products in the region. Additionally, the presence of several key players in the region, coupled with favorable government initiatives, is expected to boost the growth of the androstenedione market in the Asia Pacific.
Access full Report Description, TOC, Table of Figure, Chart, etc:
While North America and Europe are also expected to witness significant growth in the androstenedione market, the Asia Pacific region is likely to lead the growth, driven by factors such as increasing population, rising prevalence of reproductive disorders, and growing awareness about family planning.
Competitive Landscape – Global Androstenedione Market The androstenedione market is a significant competitor, and extremely cutthroat in the sector are using strategies including product launches, partnerships, acquisitions, agreements, and growth to enhance their market positions. Most sector businesses focus on increasing their operations worldwide and cultivating long-lasting partnerships.
Request For Report Description:
Major key players in the global androstenedione market are: Teva Pharmaceutical Industries Ltd. Pfizer Mylan N.V. BIOVET Indo Phyto Chemicals Goto Pharmaceutical Kaizon Jiufu Darui Yongning Pharma Dahua Pharmaceutical Sito Bio Dongyao Pharmaceutical Huazong Pharmaceuticals
Browse Top 5 Industrial Equipment & Machining Market Research Report
Pre-Insulated Pipes Market
Diaphragm Pumps Market
Industrial Gear Market
Intelligent Process Automation Market
Advanced Space Composites Market
About Market Statsville Group
market statsville group (msg) is a business research and consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and intelligent business insights. MSG has experienced research analysts who are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact. Furthermore, Market Statsville Group already benefited more than 1,000 companies each year for their revenue planning. It helped them take their disruptions/innovations early to the market by providing them research ahead of the curve.
MSG has an entire repository of research reports on more than 1,000 niche industries, 3,000 high-growth potentials markets, 5,000 data sets, and more than 12,000 company profiles.
Contact Us:
Market Statsville Group (MSG)
800 Third Avenue Suite A #1519
New York, US 10022
USA: +1 646-663-5829 | +91 702 496 8807
Email:
Web: